BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Goyal Y, Busch GT, Pillai M, et al. (2023) Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells. Nature |
| Alicea GM, Portuallo ME, Patel P, et al. (2023) Age-related increases in IGFBP2 increase melanoma cell invasion and lipid synthesis. Biorxiv : the Preprint Server For Biology |
| Fane ME, Ecker BL, Kaur A, et al. (2023) Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 29: 2012 |
| Dardani I, Emert BL, Goyal Y, et al. (2022) ClampFISH 2.0 enables rapid, scalable amplified RNA detection in situ. Nature Methods |
| Fane ME, Chhabra Y, Alicea GM, et al. (2022) Stromal changes in the aged lung induce an emergence from melanoma dormancy. Nature |
| Erbe R, Wang Z, Wu S, et al. (2021) Evaluating the impact of age on immune checkpoint therapy biomarkers. Cell Reports. 36: 109599 |
| Torre EA, Arai E, Bayatpour S, et al. (2021) Genetic screening for single-cell variability modulators driving therapy resistance. Nature Genetics |
| Fane ME, Ecker BL, Kaur A, et al. (2020) sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Alicea GM, Rebecca VW, Goldman AR, et al. (2020) Changes in Aged Fibroblast Lipid Metabolism Induce Age-dependent Melanoma Cell Resistance to Targeted Therapy Via the Fatty Acid Transporter FATP2. Cancer Discovery |
| Webster MR, Fane ME, Alicea GM, et al. (2020) Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma. Molecular Cell. 77: 681 |